|
|
Blood, 1 January 2005, Vol. 105, No. 1, pp. 376-381.
Prepublished online as a Blood First Edition Paper on September 2, 2004; DOI 10.1182/blood-2004-04-1416.
 Previous Article | Table of Contents | Next Article 
RED CELLS
Expression of hepcidin is down-regulated in TfR2 mutant mice manifesting a phenotype of hereditary hemochromatosis
Hiroshi Kawabata,
Robert E. Fleming,
Dorina Gui,
Seo Y. Moon,
Takayuki Saitoh,
James O'Kelly,
Yutaka Umehara,
Yuji Wano,
Jonathan W. Said, and
H. Phillip Koeffler
From the Division of Hematology/Oncology, Cedars-Sinai Medical Center, Los Angeles, CA; the Department of Pediatrics, St Louis University School of Medicine, St Louis, MO; the Department of Pathology and Laboratory Medicine, UCLA School of Medicine, Los Angeles, CA; the Department of Surgery, Cedars-Sinai Medical Center, Los Angeles, CA; and the Division of Hematology/Immunology, Kanazawa Medical University, Uchinada, Ishikawaken, Japan.
Transferrin receptor 2 (TfR2) is a membrane glycoprotein that mediates cellular iron uptake from holotransferrin. Homozygous mutations of this gene cause one form of hereditary hemochromatosis in humans. We recently reported that homozygous TfR2(Y245X) mutant mice, which correspond to the TfR2(Y250X) mutation in humans, showed a phenotype similar to hereditary hemochromatosis. In this study, we further analyzed the phenotype as well as iron-related gene expression in these mice by comparing the TfR2-mutant and wild-type siblings. Northern blot analyses showed that the levels of expression of hepcidin mRNA in the liver were generally lower, whereas those of duodenal DMT1, the main transporter for uptake of dietary iron, were higher in the TfR2-mutant mice as compared to the wild-type siblings. Expression of hepcidin mRNA in the TfR2 mutant mice remained low even after intraperitoneal iron loading. In isolated hepatocytes from both wild-type and TfR2 mutant mice, interleukin-6 and lipopolysaccharide each induced expression of hepcidin mRNA. These results suggest that up-regulation of hepcidin expression by inflammatory stimuli is independent of TfR2 and that TfR2 is upstream of hepcidin in the regulatory pathway of body iron homeostasis. (Blood. 2005;105:376-381)
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
F. Marques, A. M. Falcao, J. C. Sousa, G. Coppola, D. Geschwind, N. Sousa, M. Correia-Neves, and J. A. Palha
Altered Iron Metabolism Is Part of the Choroid Plexus Response to Peripheral Inflammation
Endocrinology,
June 1, 2009;
150(6):
2822 - 2828.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. G. K. Tan, M. P. Kumarasinghe, S. M. Wang, L. L. P. J. Ooi, S. E. Aw, and K. M. Hui
Modulation of Iron-Regulatory Genes in Human Hepatocellular Carcinoma and Its Physiological Consequences
Experimental Biology and Medicine,
June 1, 2009;
234(6):
693 - 702.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. Ramey, J.-C. Deschemin, and S. Vaulont
Cross-talk between the mitogen activated protein kinase and bone morphogenetic protein/hemojuvelin pathways is required for the induction of hepcidin by holotransferrin in primary mouse hepatocytes
Haematologica,
June 1, 2009;
94(6):
765 - 772.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A.-S. Zhang and C. A. Enns
Iron Homeostasis: Recently Identified Proteins Provide Insight into Novel Control Mechanisms
J. Biol. Chem.,
January 9, 2009;
284(2):
711 - 715.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
N. C. Andrews
Forging a field: the golden age of iron biology
Blood,
July 15, 2008;
112(2):
219 - 230.
[Full Text]
[PDF]
|
|
|
|
|
|
|
X. Du, E. She, T. Gelbart, J. Truksa, P. Lee, Y. Xia, K. Khovananth, S. Mudd, N. Mann, E. M. Y. Moresco, et al.
The Serine Protease TMPRSS6 Is Required to Sense Iron Deficiency
Science,
May 23, 2008;
320(5879):
1088 - 1092.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. Aigner, I. Theurl, M. Theurl, D. Lederer, H. Haufe, O. Dietze, M. Strasser, C. Datz, and G. Weiss
Pathways underlying iron accumulation in human nonalcoholic fatty liver disease
Am. J. Clinical Nutrition,
May 1, 2008;
87(5):
1374 - 1383.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. F. Wallace, L. Summerville, E. M. Crampton, and V. N. Subramaniam
Defective trafficking and localization of mutated transferrin receptor 2: implications for type 3 hereditary hemochromatosis
Am J Physiol Cell Physiol,
February 1, 2008;
294(2):
C383 - C390.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Truksa, H. Peng, P. Lee, and E. Beutler
Bone morphogenetic proteins 2, 4, and 9 stimulate murine hepcidin 1 expression independently of Hfe, transferrin receptor 2 (Tfr2), and IL-6
PNAS,
July 5, 2006;
103(27):
10289 - 10293.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D F Wallace, L Summerville, P E Lusby, and V N Subramaniam
First phenotypic description of transferrin receptor 2 knockout mouse, and the role of hepcidin
Gut,
July 1, 2005;
54(7):
980 - 986.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
I. De Domenico, D. M. Ward, E. Nemeth, M. B. Vaughn, G. Musci, T. Ganz, and J. Kaplan
The molecular basis of ferroportin-linked hemochromatosis
PNAS,
June 21, 2005;
102(25):
8955 - 8960.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. M. Schimanski, H. Drakesmith, A. T. Merryweather-Clarke, V. Viprakasit, J. P. Edwards, E. Sweetland, J. M. Bastin, D. Cowley, Y. Chinthammitr, K. J. H. Robson, et al.
In vitro functional analysis of human ferroportin (FPN) and hemochromatosis-associated FPN mutations
Blood,
May 15, 2005;
105(10):
4096 - 4102.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
